Progress of Different Programmed Cell Death Pathways in Kidney Cancer

Programmed cell death (PCD) is a genetically determined, active and orderly cell death in the organism, and it affects the evolution of the organism, maintenance of its homeostasis, and development of several tissues and organs. The abnormal regulation of this process is closely related to various h...

Full description

Bibliographic Details
Main Authors: WU Mingzhe, WANG Fuchun, PAN Haojie, ZHOU An'an, XIAO Xi, TIAN Junqiang
Format: Article
Language:zho
Published: Magazine House of Cancer Research on Prevention and Treatment 2023-05-01
Series:Zhongliu Fangzhi Yanjiu
Subjects:
Online Access:http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2023.22.1100
_version_ 1797808867307945984
author WU Mingzhe
WANG Fuchun
PAN Haojie
ZHOU An'an
XIAO Xi
TIAN Junqiang
author_facet WU Mingzhe
WANG Fuchun
PAN Haojie
ZHOU An'an
XIAO Xi
TIAN Junqiang
author_sort WU Mingzhe
collection DOAJ
description Programmed cell death (PCD) is a genetically determined, active and orderly cell death in the organism, and it affects the evolution of the organism, maintenance of its homeostasis, and development of several tissues and organs. The abnormal regulation of this process is closely related to various human diseases, including cancer. The identified pathways of PCD include apoptosis, autophagy, necroptosis, pyroptosis, and ferroptosis, which can be activated when cells are stimulated by various internal and external environmental factors. These pathways can induce cell death or maintain cell survival in kidney cancer cells under the regulation of various signaling molecules, thus affecting tumor progression or therapeutic efficacy. In this paper, the role of these PCD pathways in the development of kidney cancer was reviewed in light of recent research advances to provide new directions for the in-depth study of the pathogenesis of kidney cancer and the development of targeted antitumor drugs.
first_indexed 2024-03-13T06:44:02Z
format Article
id doaj.art-2aaf674435494d10860854e98920f57b
institution Directory Open Access Journal
issn 1000-8578
language zho
last_indexed 2024-03-13T06:44:02Z
publishDate 2023-05-01
publisher Magazine House of Cancer Research on Prevention and Treatment
record_format Article
series Zhongliu Fangzhi Yanjiu
spelling doaj.art-2aaf674435494d10860854e98920f57b2023-06-08T10:42:08ZzhoMagazine House of Cancer Research on Prevention and TreatmentZhongliu Fangzhi Yanjiu1000-85782023-05-0150553153710.3971/j.issn.1000-8578.2023.22.11008578.2023.22.1100Progress of Different Programmed Cell Death Pathways in Kidney CancerWU Mingzhe0WANG Fuchun1PAN Haojie2ZHOU An'an3XIAO Xi4TIAN Junqiang5Department of Urology, The Second Hospital of Lanzhou University, Lanzhou 730000, ChinaDepartment of Infectious Diseases, The First Hospital of Lanzhou University, Lanzhou 730000, ChinaDepartment of Urology, The Second Hospital of Lanzhou University, Lanzhou 730000, ChinaDepartment of Urology, The Second Hospital of Lanzhou University, Lanzhou 730000, ChinaDepartment of Urology, The Second Hospital of Lanzhou University, Lanzhou 730000, ChinaDepartment of Urology, The Second Hospital of Lanzhou University, Lanzhou 730000, ChinaProgrammed cell death (PCD) is a genetically determined, active and orderly cell death in the organism, and it affects the evolution of the organism, maintenance of its homeostasis, and development of several tissues and organs. The abnormal regulation of this process is closely related to various human diseases, including cancer. The identified pathways of PCD include apoptosis, autophagy, necroptosis, pyroptosis, and ferroptosis, which can be activated when cells are stimulated by various internal and external environmental factors. These pathways can induce cell death or maintain cell survival in kidney cancer cells under the regulation of various signaling molecules, thus affecting tumor progression or therapeutic efficacy. In this paper, the role of these PCD pathways in the development of kidney cancer was reviewed in light of recent research advances to provide new directions for the in-depth study of the pathogenesis of kidney cancer and the development of targeted antitumor drugs.http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2023.22.1100kidney cancerprogrammed cell deathapoptosisautophagynecroptosispyroptosisferroptosis
spellingShingle WU Mingzhe
WANG Fuchun
PAN Haojie
ZHOU An'an
XIAO Xi
TIAN Junqiang
Progress of Different Programmed Cell Death Pathways in Kidney Cancer
Zhongliu Fangzhi Yanjiu
kidney cancer
programmed cell death
apoptosis
autophagy
necroptosis
pyroptosis
ferroptosis
title Progress of Different Programmed Cell Death Pathways in Kidney Cancer
title_full Progress of Different Programmed Cell Death Pathways in Kidney Cancer
title_fullStr Progress of Different Programmed Cell Death Pathways in Kidney Cancer
title_full_unstemmed Progress of Different Programmed Cell Death Pathways in Kidney Cancer
title_short Progress of Different Programmed Cell Death Pathways in Kidney Cancer
title_sort progress of different programmed cell death pathways in kidney cancer
topic kidney cancer
programmed cell death
apoptosis
autophagy
necroptosis
pyroptosis
ferroptosis
url http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2023.22.1100
work_keys_str_mv AT wumingzhe progressofdifferentprogrammedcelldeathpathwaysinkidneycancer
AT wangfuchun progressofdifferentprogrammedcelldeathpathwaysinkidneycancer
AT panhaojie progressofdifferentprogrammedcelldeathpathwaysinkidneycancer
AT zhouanan progressofdifferentprogrammedcelldeathpathwaysinkidneycancer
AT xiaoxi progressofdifferentprogrammedcelldeathpathwaysinkidneycancer
AT tianjunqiang progressofdifferentprogrammedcelldeathpathwaysinkidneycancer